Alzamend Neuro (ALZN) director McGrath bought 10,000 shares for $4,350 at $0.44
Insider transactions reported
Lynne Fahey McGrath (director at Alzamend Neuro Inc., ALZN) reported that they bought 10,000 shares for $4,350 at $0.44 on Mar 22, 2023. After these transactions the filing shows 10,000 shares held indirectly (By Spouse).
- Reporting person
- McGrath Lynne Fahey
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Mar 22, 2023 | Open-market purchase (P) | Common Stock1 | +10,000 | $0.44 | $4,350 | 10,000 indirect |
Holdings before and after
- Common Stock: 0 to 10,000 indirect, By Spouse
Other positions listed
- Common Stock: 75,000 direct
Footnotes from the filing
- 1. The shares were purchased in an individual retirement account owned by Mrs. McGrath's spouse. Mrs. McGrath disclaims beneficial ownership of the shares held by her spouse, and the inclusion of these shares shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did McGrath report in this ALZN Form 4?
Lynne Fahey McGrath (director at Alzamend Neuro Inc., ALZN) reported that they bought 10,000 shares for $4,350 at $0.44 on Mar 22, 2023. After these transactions the filing shows 10,000 shares held indirectly (By Spouse).
How many ALZN shares does McGrath hold after this filing?
The filing shows 10,000 shares held indirectly (By Spouse) after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for ALZN
Earlier insider filings at ALZN
- Mar 20, 2023SEC Form 4 filed by Alzamend Neuro Inc.
- Feb 28, 2023SEC Form 4: Horne William B. exercised 500,000 shares at a strike of $0.00, increasing direct ownership by 100% to 1,000,000 units
- Feb 18, 2023SEC Form 4: Ault Milton C Iii bought $597 worth of shares (1,000 units at $0.60)
- Dec 29, 2022SEC Form 4: Ault Milton C Iii bought $2,277 worth of shares (4,000 units at $0.57)
- Dec 23, 2022SEC Form 4: Ault Milton C Iii bought $4,049 worth of shares (5,000 units at $0.81)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Follow ALZN and get a push notification the moment its next story breaks.